Whatever your role in the drug development and approval process, PharmaPendium can help.

PharmaPendium provides powerful decision support by giving you unprecedented access to best-in-class drug development information.

The only online resource to hold FDA approval documentation since 1938, as well as valuable EMEA EPARs, PharmaPendium gives you unrivalled insights into the entire history of drug development. 

PharmaPendium offers:

• Searchable FDA and EMEA approval packages.
• The PharmaPendium Classic collection, containing archived FDA approval documentation from 1938 – 1992.
• Carefully extracted adverse event and toxicity data from preclinical and clinical studies, as well as a database of post market event reports – allowing you to view which studies’ results translate successfully from animal to human, or from clinical to post-marketing.
• Data search function by text or chemical structures or data pathway browsing by drug, adverse event/toxicity and target.

Helping you to:

• Quickly find the information you need – without having to order relevant packages and scan through printed documents.
• Easily generate, retrieve and compare information.
• Reduce the risk of submission mistakes with access to critical insights into the FDA and EMEA approval precedents, highlighting where previous submissions have succeeded or been delayed.
• Reduce development costs by learning from approved drugs and identifying drug safety risks earlier.